159 related articles for article (PubMed ID: 33335840)
1. Zellweger spectrum disorder: A cross-sectional study of symptom prevalence using input from family caregivers.
Bose M; Cuthbertson DD; Fraser MA; Roullet JB; Gibson KM; Schules DR; Gawron KM; Gamble MB; Sacra KM; Lopez MJ; Rizzo WB
Mol Genet Metab Rep; 2020 Dec; 25():100694. PubMed ID: 33335840
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Severity in Zellweger Spectrum Disorder by Clinical Findings: A Scoping Review, Meta-Analysis and Medical Chart Review.
Bose M; Yergeau C; D'Souza Y; Cuthbertson DD; Lopez MJ; Smolen AK; Braverman NE
Cells; 2022 Jun; 11(12):. PubMed ID: 35741019
[TBL] [Abstract][Full Text] [Related]
3. Emotional experience in parents of children with Zellweger spectrum disorders: A qualitative study.
Bose M; Mahadevan M; Schules DR; Coleman RK; Gawron KM; Gamble MB; Roullet JB; Gibson KM; Rizzo WB
Mol Genet Metab Rep; 2019 Jun; 19():100459. PubMed ID: 30815361
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic challenges and disease management in patients with a mild Zellweger spectrum disorder phenotype.
Enns GM; Ammous Z; Himes RW; Nogueira J; Palle S; Sullivan M; Ramirez C
Mol Genet Metab; 2021 Nov; 134(3):217-222. PubMed ID: 34625341
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a severity scoring system for Zellweger spectrum disorders.
Klouwer FCC; Meester-Delver A; Vaz FM; Waterham HR; Hennekam RCM; Poll-The BT
Clin Genet; 2018 Mar; 93(3):613-621. PubMed ID: 28857144
[TBL] [Abstract][Full Text] [Related]
6. A metabolomic map of Zellweger spectrum disorders reveals novel disease biomarkers.
Wangler MF; Hubert L; Donti TR; Ventura MJ; Miller MJ; Braverman N; Gawron K; Bose M; Moser AB; Jones RO; Rizzo WB; Sutton VR; Sun Q; Kennedy AD; Elsea SH
Genet Med; 2018 Oct; 20(10):1274-1283. PubMed ID: 29419819
[TBL] [Abstract][Full Text] [Related]
7. A Retrospective Study of Hearing Loss in Patients Diagnosed with Peroxisome Biogenesis Disorders in the Zellweger Spectrum.
Lee J; Yergeau C; Kawai K; Braverman N; Géléoc GSG
Ear Hear; 2022; 43(2):582-591. PubMed ID: 34534157
[TBL] [Abstract][Full Text] [Related]
8. Zellweger Spectrum Disorder: Ophthalmic Findings from a New Natural History Study Cohort and Scoping Literature Review.
Yergeau C; Coussa RG; Antaki F; Argyriou C; Koenekoop RK; Braverman NE
Ophthalmology; 2023 Dec; 130(12):1313-1326. PubMed ID: 37541626
[TBL] [Abstract][Full Text] [Related]
9. Chinese patients with adrenoleukodystrophy and Zellweger spectrum disorder presenting with hereditary spastic paraplegia.
Chen YJ; Wang MW; Dong EL; Lin XH; Wang N; Zhang ZQ; Lin X; Chen WJ
Parkinsonism Relat Disord; 2019 Aug; 65():256-260. PubMed ID: 31227335
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of C26:0-lysophosphatidylcholine and C26:0-carnitine as diagnostic markers for Zellweger spectrum disorders.
Klouwer FCC; Ferdinandusse S; van Lenthe H; Kulik W; Wanders RJA; Poll-The BT; Waterham HR; Vaz FM
J Inherit Metab Dis; 2017 Nov; 40(6):875-881. PubMed ID: 28677031
[TBL] [Abstract][Full Text] [Related]
11. Low bone mineral density is a common feature of Zellweger spectrum disorders.
Rush ET; Goodwin JL; Braverman NE; Rizzo WB
Mol Genet Metab; 2016 Jan; 117(1):33-7. PubMed ID: 26643206
[TBL] [Abstract][Full Text] [Related]
12. Histologic and ultrastructural features in early and advanced phases of Zellweger spectrum disorder (infantile Refsum disease).
Warren M; Mierau G; Wartchow EP; Shimada H; Yano S
Ultrastruct Pathol; 2018; 42(3):220-227. PubMed ID: 29482424
[TBL] [Abstract][Full Text] [Related]
13. Liver disease predominates in a mouse model for mild human Zellweger spectrum disorder.
Berendse K; Boek M; Gijbels M; Van der Wel NN; Klouwer FC; van den Bergh-Weerman MA; Shinde AB; Ofman R; Poll-The BT; Houten SM; Baes M; Wanders RJA; Waterham HR
Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2774-2787. PubMed ID: 31207289
[TBL] [Abstract][Full Text] [Related]
14. Accurate and live peroxisome biogenesis evaluation achieved by lentiviral expression of a green fluorescent protein fused to a peroxisome targeting signal 1.
Demaret T; Courtoy GE; Ravau J; Van Der Smissen P; Najimi M; Sokal EM
Histochem Cell Biol; 2020 May; 153(5):295-306. PubMed ID: 32124009
[TBL] [Abstract][Full Text] [Related]
15. Two novel mutations of
Yu HL; Shen Y; Sun YM; Zhang Y
Ann Transl Med; 2019 Aug; 7(16):368. PubMed ID: 31555682
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal study of Pex1-G844D NMRI mouse model: A robust pre-clinical model for mild Zellweger spectrum disorder.
Demaret T; Roumain M; Ambroise J; Evraerts J; Ravau J; Bouzin C; Bearzatto B; Gala JL; Stepman H; Marie S; Vincent MF; Muccioli GG; Najimi M; Sokal EM
Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165900. PubMed ID: 32693164
[TBL] [Abstract][Full Text] [Related]
17. Mild Zellweger syndrome due to functionally confirmed novel PEX1 variants.
Lipiński P; Stawiński P; Rydzanicz M; Wypchło M; Płoski R; Stradomska TJ; Jurkiewicz E; Ferdinandusse S; Wanders RJA; Vaz FM; Tylki-Szymańska A
J Appl Genet; 2020 Feb; 61(1):87-91. PubMed ID: 31628608
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic Hematopoietic Stem Cell Transplantation for PEX1-Related Zellweger Spectrum Disorder: A Case Report and Literature Review.
Chen K; Zhang N; Shao JB; Li H; Li J; Xi JM; Xu WH; Jiang H
Front Pediatr; 2021; 9():672187. PubMed ID: 34513757
[TBL] [Abstract][Full Text] [Related]
19. High incidence of hyperoxaluria in generalized peroxisomal disorders.
van Woerden CS; Groothoff JW; Wijburg FA; Duran M; Wanders RJ; Barth PG; Poll-The BT
Mol Genet Metab; 2006 Aug; 88(4):346-50. PubMed ID: 16621644
[TBL] [Abstract][Full Text] [Related]
20. Zellweger Syndrome Disorders: From Severe Neonatal Disease to Atypical Adult Presentation.
Cheillan D
Adv Exp Med Biol; 2020; 1299():71-80. PubMed ID: 33417208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
